The Russian pharmaceutical industry has faced a shortage of chromatographic columns due to the refusal of Western companies to supply components, Kommersant has learned. The devices are used in the development of new drugs, for quality control at every stage in the production of already registered drugs, allowing the detection of foreign impurities.

Some pharmaceutical manufacturers are forced to replenish stocks of chromatographic columns by purchasing them from third-party intermediaries. This is done, for example, by the drug manufacturer Vertex, but such purchases "cost exorbitantly" and involve serious difficulties and risks. In addition, the pharmaceutical company cannot replace the products with which it worked, and it is not produced in Russia, and any change of supplier is accompanied by changes in documentation and a complex bureaucratic process, they note.

Aquachrome stated that they are testing the products of one of the Chinese companies, another pharmaceutical company Active Component plans to find a replacement for components in China.

The shortage of chromatographic columns does not exhaust the difficulties of pharmaceutical manufacturers, one of the interlocutors of the newspaper noted. A much more serious problem may be with chromatographs, the import of which to Russia, unlike columns, is prohibited under EU sanctions, which is why many pharmaceutical manufacturers will not be able to update this equipment and will lose service, two distributors noted.

Read the operational news in ourTelegram channel

Author: Ulyana Lutskevich
Made in Russia // Made in Russia

#made by Russia